魔方导航
自由容器
ABOUT US
Leverage Advanced Science and Technology for Human Health
Joint Therapeutics Co., Ltd. was initiated in August 2022 and is a biotechnology company dedicated to innovative drug research and development, production, and ultimately promoting clinical applications. The company adopts a business model of "novel drugs as the core, with technology and product services as two wings". The core team members are the frontline personnels in the medical research and clinical service, including multiple overseas professionals and high-level national talents. We are committed to transforming cutting-edge scientific and technological innovation into innovative drugs and methods for clinical diagnosis and treatment, ultimately improving human health.
NEWS
‍
The company launched a series of stem cell culture media and supporting reagents
Joint Therapeutics Co., Ltd. has recently launched a series of efficient stem cell culture and differentiation media, as well as supporting staining reagents. The media and reagent formulas are fro...
2024/03/02
【Technical Services】 Pengge Pharmaceutical Gene Editing Technology Platform is fully operational
Gene editing is a technology that modifies specific genes by modifying the genome sequence of an organism. This technology utilizes gene editing tools, such as the CRISPR-Cas9 system, to accurately...
2023/12/25
【New Product】 The company launches a Hematoxylin-Eosin (H&E)Stain Kit
Hematoxylin-Eosin (H&E) stain is one of the widely used and classic cell histological staining methods in the field of biomedicine, widely used in medicine, biology, and other fields. This staining...
2023/12/15
【New Product】 The company launches a series of culture media for stem cell osteogenesis, cartilage,
Stem cells and regenerative medicine are one of the future directions of medical development, and also provide unlimited possibilities for disease treatment. Multidirectional differentiation potent...
2023/12/11
【Shocking IPO】 The company launches a series of stem cell culture media
Joint Therapeutics Co., Ltd. has accumulated 20 years of research and development experience from its core technology team both domestically and internationally. With outstanding technical capabili...
2023/12/05
【Technical Service】 DMM (Destabilization of Medial Meniscus) model of osteoarthritis in mice
Osteoarthritis is a common joint disease, affecting the quality of life of hundreds of millions of people around the world. DMM (Destabilization of Medial Meniscus) is an internationally recognized...
2023/11/24
【 New Products 】 The company launches Safranin O-Fast Green Stain reagent kit
The safranine O-fixed green staining method is a classic biological technique for staining cartilage, which is based on the principle that basophilic cartilage combines with the alkaline dye safran...
2023/11/20
【 Good News 】 The company's project won the winning award in the 2nd National Postdoctoral Innovatio
On October 26-28, the final of the second National Postdoctoral Innovation and Entrepreneurship Competition, themed "Smart Hui Empowerment, Development, and Leading the Future", was held in Yantai,...
2023/11/20
Warmly celebrate the launch of the official website of Joint Therapeutics Co., Ltd.
Joint Therapeutics Co., Ltd.was established in August 2022 and is a biotechnology company dedicated to innovative drug research and development, production, and ultimately promoting clinical applic...
2023/08/17
Chief Scientist Ge Xianpeng's team eLife published a paper explaining the source and differentiation
Osteoarthritis (OA) is one of the most common types of arthritis, which can affect all synovial joints in the human body, including temporomandibular joints and limb joints. This disease mainly inv...
2023/08/17
CONTACT US
Phone：+86-010-53689023

Address：No. 88 Kechuang 6th Street, Beijing Economic and Technological Development Zone, Beijing

Email：office@penggegroup.com

©2019-2023 Pengge (Beijing) Pharmaceutical Co., Ltd Copyright